GeoPharma (GORX) Reports a Q1 Loss
GeoPharma, Inc. (Nasdaq: GORX) reports a Q1 loss of $0.05 compared to a loss of $0.01 for the same period last year. Revenues were $5.2 million compared to $6.4 million for the same period last year.
[SM]
[SM]
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Signet Jewelers (SIG) Tops Q1 EPS by 5c; Guides Q2 Below the Street
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
